Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 8/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.37 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 3/20 | 0.33 |
| ▸ | NOS1 | P29475 | 3/20 | 0.33 |
| ▸ | NOS2 | P35228 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | CPB1 | P15086 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3344370 | 1.00 | CPB2 (0.40) | CPB2GSRRNPEPGABRR1CYP1A2 | |
| SCHEMBL15450729 | 0.79 | CPB2 (0.44) | CPB2GSRRNPEPGABRR1CYP1A2 | |
| SCHEMBL8955201 | 0.77 | CPB2 (0.37) | CPB2GSRRNPEP | |
| SCHEMBL8955445 | 0.75 | GSR (0.41) | CPB2GSRRNPEPGABRR1CYP1A2 | |
| SCHEMBL15220492 | 0.73 | GSR (0.50) | CPB2GSRRNPEPGABRR1CYP1A2 | |
| SCHEMBL8955235 | 0.73 | GSR (0.42) | CPB2GSRRNPEPCPB1 | |
| SCHEMBL11264534 | 0.72 | CPB2 (0.45) | CPB2GSRRNPEPGABRR1CYP1A2 | |
| SCHEMBL28477850 | 0.69 | CPB2 (0.42) | CPB2GSRRNPEPGABRR1CYP1A2 | |
| SCHEMBL27501941 | 0.69 | CPB2 (0.42) | CPB2GSRRNPEPGABRR1CYP1A2 | |
| SCHEMBL27553716 | 0.68 | GSR (0.54) | CPB2GSRRNPEPGABRR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100158857-A1 | Compositions and methods for the inhibition of endothelial nitric oxide synthase activity | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2010-06-24 | — | — | US | claimed |
| EP-2020998-A1 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVITY | University of Utah Research Foundation (US) | 2009-02-11 | — | — | EP | claimed |
| WO-2007139897-A1 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVITY | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2007-12-06 | — | — | WO | claimed |
| US-6656925-B2 | Composition and method of treating arthritis | ADVANCED MEDICAL INSTRUMENTS | 2003-12-02 | — | — | US | claimed |
| US-20020119952-A1 | Composition and method of treating arthritis | ADVANCED MEDICAL INSTRUMENTS | 2002-08-29 | — | — | US | claimed |
| US-6043268-A | Agent for treatment of viral infections | Maeda, Hiroshi (JP) | 2000-03-28 | — | — | US | claimed |
| US-20240024363-A1 | TREATMENT OF LIMB ISCHEMIA BY BONE MARROW STEM CELLS AND MODIFICATION OF DISEASED MICROENVIRONMENT | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-01-25 | — | — | US | disclosed |
| US-20230330193-A1 | ENHANCEMENT OF STEM CELL THERAPY FOR CARTILAGE DEGENERATION BY ANTI-OXIDANT PRE-CONDITIONING | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2023-10-19 | — | — | US | disclosed |
| CN-106163553-B | Compositions of multimeric-multiepitope influenza polypeptides and production thereof | 彼昂德瓦克斯医药有限公司 | 2021-07-23 | — | — | CN | disclosed |
| US-10426828-B2 | Compositions of multimeric-multiepitope influenza polypeptides and their production | BIONDVAX PHARMACEUTICALS LTD. (IL) | 2019-10-01 | — | — | US | disclosed |
| US-20170173142-A1 | COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION | BIONDVAX PHARMACEUTICALS LTD. (IL) | 2017-06-22 | — | — | US | disclosed |
| EP-3125931-A1 | COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION | Biondvax Pharmaceuticals Ltd. (IL) | 2017-02-08 | — | — | EP | disclosed |
| WO-2015151103-A1 | COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION | BIONDVAX PHARMACEUTICALS LTD. (IL) | 2015-10-08 | — | — | WO | disclosed |
| US-20100158857-A1 | Compositions and methods for the inhibition of endothelial nitric oxide synthase activity | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2010-06-24 | — | — | US | disclosed |
| EP-2020998-A1 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVITY | University of Utah Research Foundation (US) | 2009-02-11 | — | — | EP | disclosed |
| WO-2007139897-A1 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVITY | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007067966-A1 | METHOD AND FORMULA FOR PREVENTION OF COLD AND FLU AND SUPPRESSION OF RELATED SYMPTOMS | CELL IONIX, INC. (US) | 2007-06-14 | — | — | WO | disclosed |
| US-6043268-A | Agent for treatment of viral infections | Maeda, Hiroshi (JP) | 2000-03-28 | — | — | US | disclosed |